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Proton therapy is increasingly being actively used in the treatment of cancer. In contrast to photons, protons 
have the potential advantage of delivering higher doses to the cancerous tissue and lower doses to the surrounding 
normal tissue. However, a range shifter is needed to degrade the beam energy in order to apply the pencil beam 
scanning technique to tumors located close to the minimum range. The secondary neutrons are produced in 
the beam path including within the patient's body as a result of nuclear interactions. Therefore, unintended side 
effects may possibly occur. The research related to the secondary neutrons generated during proton therapy has 
been presented in a variety of studies worldwide, since 2007. In this study, we measured the magnitude of the 
secondary neutron dose depending on the location of the detector and the use of a range shifter at the beam 
nozzle of the proton scanning mode, which was recently installed. In addition, the production of secondary 
neutrons was measured and estimated as a function of the distance between the isocenter and detector. The 
neutron dose was measured using WENDI-II (Wide Energy Neutron Detection Instruments) and a Plastic Water 
phantom; a Zebra dosimeter and 4-cm-thick range shifter were also employed as a phantom. In conclusion, 
we need to consider the secondary neutron dose at proton scanning facilities to employ the range shifter 
reasonably and effectively.
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Introduction
  Proton therapy has been actively used to treat cancers and 
its use is increasing globally.1,2) Currently, new proton therapy 
centers are under construction or being test-driven in the US, 
Japan, and the EU; plans for the construction of more accel-
erators are being considered.3) 
  The Bragg peak, a unique property of a proton beam, is su-
perior, compared to other cancer therapy techniques, in se-
lectively transferring a relatively small dose to normal tissues 
and a maximum dose to tumor tissues.4) 
  Proton therapy methods are largely divided into scattering 
methods and scanning methods. Despite numerous advantages 
in scattering methods, intensity modulated proton therapy 
(IMPT) using scanning is being currently receiving much at-
tention, and most of the new proton therapy centers currently 
under construction apply scanning methods for treatment. 
  Although proton therapy, owing to its advantages, is used 
for treatments at numerous proton therapy centers, it has 
drawbacks. Protons interact with components in the nozzle in 
the beam path or with the nuclei of the patient, thereby gen-
erating secondary particles. The types of secondary particles 
include neutrons, protons, electrons, alpha particles, and heav-
ier fragments. Secondary neutrons generated by a proton beam 
may cause other problems besides the patient treatment due to 
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Fig. 1. Range shifter.
their high relative biological effectiveness (RBE) and penetrat-
ing power in comparison to other photons.5,6) 
  Secondary neutrons are one of the major factors that cause 
the increase of the total dose and secondary cancers of patients 
by affecting the integral dose.7) Secondary neutrons are com-
monly divided into external neutrons and internal neutrons, 
where external neutrons are defined as neutrons within the 
nozzle of a proton treatment device and internal neutrons are 
defined as neutrons generated by interactions between the pro-
ton beam and the patient. 
  Scanning methods, compared to scattering treatment meth-
ods, generate fewer secondary particles owing to the fact that 
there are fewer internal components within nozzle, such as the 
scattering foil and the modulator wheel. Various studies on 
secondary neutrons have been conducted around the world 
since 2007, reporting simulations or measurements of neutron 
emission from individual therapy centers.8-10)
  Study results vary from center to center, impairing direct 
comparisons. The results vary because individual centers have 
different proton therapy facility designs and beam conditions. 
Furthermore, scanning nozzles are designed slightly differently 
depending on their intended purpose, and the neutron doses re-
sulting from different scanning nozzle designs should be con-
sidered, although research with such consideration is lacking. 
Furthermore, owing to the limit of the energy generated by the 
accelerators, a range shifter is required to treat near skin tu-
mors, where protons transfer energy to the surrounding skin; 
however, there have been few studies on the impacts of neu-
trons with the use of range shifter. 
  Accordingly, to analyze shielding implications for secondary 
neutrons generated from a range shifter used in proton therapy 
equipment recently installed in South Korea, this study meas-
ured and assessed neutron emission based on the presence and 
location of a range shifter for a nozzle used in a scanning 
method. Furthermore, the study measured and assessed neutron 
emission based on the measurement distance of the detector.
Materials and Methods
  A range shifter, in the context of cancer treatment, is a 
component that reduces the proton range by reducing the en-
ergy of the proton beam. The minimum energy of a proton 
beam, commonly available in proton therapy centers, is 70 
MeV, which gives a depth of water propagation of 3.4 cm, 
which limits the treatment of near-skin tumors. When tumors 
are located close to the surface of the skin, the minimum 
range of the proton beam becomes a hurdle to treatment that 
may be overcome by lowering the proton range with a range 
shifter. In tumor treatments using a range shifter, materials are 
located on the beam path, generating additional nuclear re-
actions with protons and thereby producing secondary 
neutrons. Fig. 1 shows a range shifter used in proton therapy 
by the Samsung Medical Center in Seoul. The range shifter is 
4 cm thick and made of polyethylene.
  In this study, secondary neutron emissions were measured 
with the following equipment. The measurements were per-
formed in the scanning gantry at the Samsung Medical Center 
in Seoul.11) The gantry angle was 270o and phantoms were 
prepared with a Zebra dosimeter and Plastic Water. Neutron 
measuring devices were prepared with a WENDI-II (Wide 
Energy Neutron Detection Instrument, Thermo Scientific TM, 
USA) in which a He-3 detector is enclosed in a cylindrical 
polyethylene moderator (23 cm in diameter and 21 cm long). 
Table 1 corresponds to the technical specification of WENDI- 
II, and Fig. 2 depicts the WENDI-II used in the measure-
ment.12) This detector was calibrated at Enviro Korea, Co., 
Ltd. on September 23, 2015.
  The first experiment measured neutron emission, based on 
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Table 1. WENDI-II technical specification.
Measuring range  0.01 μSv/h to 100 mSv/h Cf-252 Gamma-sensitivity 1 to 5 μSv/h at 100 mSv/h, 662 keV
Sensitivity 0.84 cps/(μSv/h) Cf-252 Ambient temperature −30 to ＋50oC
Energy range 25 meV to 5 GeV according to ICRP 74 (1996) Humidity Up to 90% non-condensing
Angular 
 dependence 
±20% all directions Atmospheric pressure 500 to 1,500 hPa
Linearity ±20% Height 320 mm (12.6”)
Diameter 230 mm (9”) Weighting range 13.5 kg (29.8 lb)
Fig. 2. WENDI-II detector.
Fig. 3. Schematic of first experiment.
Fig. 4. Schematic of second experiment.
the distance between the neutron source and the detector, gen-
erated by a phantom in scanning treatment as follows. The 
volume of the Plastic Water phantom was 30×30×24.7 cm3, 
located at the isocenter. The phantom was irradiated by a pro-
ton beam at 230 MeV, the highest energy, to obtain the high-
est possible secondary neutron flux, and the secondary neutron 
emission generated by the phantom was measured according to 
distance between the neutron source and the detector. Neutron 
measurements were obtained at distances of 40, 60, 90, and 
110 cm from the isocenter in the beam’s transaxial direction, 
and at distances of −50, −75, and −100 cm from the iso-
center in the beam’s radial direction. Fig. 3 shows a schematic 
of this experimental setup. 
  The second experiment measured neutron emission from the 
range shifter used in scanning treatment, according to the loca-
tion of the detector as follows. After the Zebra detector was 
placed at the proton isocenter, the WENDI-II was placed at 
the first location, 100 cm in the axial direction from the iso-
center, where the secondary neutron emission was measured 
according to presence of a range shifter. The WENDI- II was 
then placed at the second measurement location, −25 cm in 
the axial direction, and 30 cm in the radial direction from the 
isocenter, where the measurements were performed again. Fig. 
4 is a schematic of this experiment and Fig. 5 describes the 
four proton scanning beam conditions used.
  Fig. 6 shows the individual measurement locations of the 
PROGRESS in MEDICAL PHYSICS  Vol. 27, No. 3, September, 2016
- 165 -
Fig. 5. Two-dimensional dosage 
distribution within phantom irra-
diated by four proton scanning 
methods to assess neutron dose 
of range shifter.
Fig. 6. Measurement of secondary 
neutron using WENDI-II. Upper 
left and right: neutron emission 
measurements taken with a range 
shifter; lower left: emission mea-
surement taken without a range 
shifter; lower right: emission mea-
surements taken from a phan-
tom.
experimental processes. The two upper figures in Fig. 6 corre-
spond to neutron dose measurements based on the presence of 
a range shifter, and the lower left figure corresponds to meas-
urements at another location without a range shifter. The lower 
right figure shows neutron emission measurements obtained 
from a phantom according to detector measurement distance in 
an actual experiment.
Results
  In the first experiment, the Plastic Water phantom, located 
at the isocenter, was irradiated with a 230 MeV proton beam; 
the neutron dose was obtained at varying distance. Table 2 
shows measurements of the secondary neutron emission from 
the isocenter in (1) the radial direction and (2) the transaxial 
direction. As shown in the table, as the distance increases, the 
secondary neutron dose decreases. This showed a similar, al-
though not identical, trend to the 1/r2 values obtained accord-
ing to the distance. Figs. 7 and 8 are graphical representations 
of Table 2, showing the secondary neutron dose according to 
the distance in the same direction.
  Table 3 shows the measurements of the neutron dose both 
with and without the range shifter with the detector in the first 
position. Although the neutron dose behind the phantom in the 
direction of the proton motion is extremely low, the neutron 
dose is higher without a range shifter, except for in Plan 1. 
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Table 2. Secondary neutron dose of a plastic water phantom at varying distance.
Energy (MeV) 230 MeV
Field size 10×10×10 cm3
Gantry angle 270o
Phantom Plastic Water phantom (30×30×24.7 cm3)
Position A B C D E F G
Detected WENDI-II
position
Radial: 
−50 cm
Radial: 
−75 cm
Radial: 
−100 cm
Trans axial:
−40 cm 
Trans axial:
−60 cm 
Trans axial:
−90 cm 
Trans axial:
−110 cm 
Neutron dose 
(mSv/Gy)
0.219 0.110 0.076 0.269 0.150 0.094 0.069
Fig. 7. Secondary neutron dose on the radial axis from 
isocenter.
Table 3. Secondary neutron dose of dedicated scanning nozzle using range shifter position 1.
Plan no. 1 2 3 4
Proton range (cm) 8.5 19.5 21 30
SOBP (cm) 3 5 8 8
Detected WENDI-II 
position
BAX: 100 cm
Neutron dose (mSv/Gy) 0.033 0.017 0.161 0.377 With 4 cm range shifter
Neutron dose (mSv/Gy) 0.009 0.088 0.219 0.461 Without 4 cm range shifter
Fig. 8. Secondary neutron dose on the beam axis from the 
isocenter.
The reason for this may be that a lower range affected neutron 
emission. However, the neutron emission was increased at the 
location of Plan 1, where the spread out bragg-peak is less 
than 4 cm long owing to the use of a 4-cm-thick range shifter.
  On the other hand, the measurements at the side position of 
the range shifter confirmed that neutron dose increased overall 
with the presence of a range shifter because all secondary neu-
trons generated from nuclear reactions between the proton 
beam and the range shift could be measured when the meas-
urement detector was located immediately behind the range 
shifter. Thus, if a patient were positioned here, the use of a 
range shifter would affect the increase in the neutron dose by 
a small amount. This study has confirmed that the neutron 
dose increases by a maximum of 39.3% at the location in Plan 
2. Furthermore, as shown in Table 4, as the volume irradiated 
with protons increases, the neutron emission increases; the 
neutron dose within the same volume is higher when the pene-
tration depth of the protons is large. Figs. 9 and 10 are graph-
ical representations of Tables 3 and 4, respectively.
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Table 4. Secondary neutron dose of dedicated scanning nozzle using range shifter position 2.
Plan no. 1 2 3 4
Proton range (cm) 8.5 19.5 21 30
SOBP (cm) 3 5 8 8
Detected WENDI-II 
position
BAX: −25 cm
Radial: 30 cm
Neutron dose (mSv/Gy) 0.028 0.085 0.324 0.456 With 4 cm range shifter
Neutron dose (mSv/Gy) 0.024 0.061 0.269 0.370 Without 4 cm range shifter
Fig. 9. Value of secondary neutron/Exp_1. Fig. 10. Value of secondary neutron/Exp_2.
Conclusion
  This study measured neutron emission in scanning treatment, 
and its relation to detector distance and the presence of a 
range shifter at the scanning gantry at the Samsung Proton 
Therapy Center in Seoul. 
  The measurement of the secondary neutron emission from a 
Plastic Water phantom in two directions confirmed that secon-
dary neutron emission decreased as detection distance increased. 
This showed a similar, though not identical, trend to the 1/r2 
values obtained at varying distance. 
  The experiment based on the presence of a range shifter 
confirmed that the range shifter affected the increase in secon-
dary neutrons. Although the results depended on measurement 
locations, the presence of a range shifter, at the same location, 
resulted in the neutron dose increasing by a maximum of 
39.3%. 
  Although scanning treatment is known to generate less neu-
tron emission than scattering methods, from the ALARA (As 
Low As Reasonably Achievable) perspective, shielding meas-
ures must be established to reduce unnecessary radiation ex-
posure to patients.13)
  Therefore, shield planning could reasonably reduce un-
necessary radiation exposure to patients by considering the re-
sults from this study at the stage of treatment planning. 
Furthermore, the next study plans to investigate secondary neu-
tron emission based on the types and thickness of range shift-
ers through FLUKA Monte Carlo simulation code, further ex-
ploring shielding measures of secondary neutrons. The results 
from this study may provide resources for other institutions to 
explore shielding of neutron emission from a range shifter dur-
ing proton scanning treatment, and the results may help to re-
duce unnecessary radiation exposure when treating patients. 
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